Cars.com
CARS
Lantheus
LNTH
Halozyme Therapeutics
HALO
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 2.39%1.2B | 6.50%316.65M | 2.88%295.14M | 1.39%290.32M | -1.21%295.14M | 7.30%1.17B | 2.57%297.32M | 4.96%286.87M | 9.22%286.33M | 12.99%298.74M |
Operating revenue | 2.39%1.2B | 6.50%316.65M | 2.88%295.14M | 1.39%290.32M | -1.21%295.14M | 7.30%1.17B | 2.57%297.32M | 4.96%286.87M | 9.22%286.33M | 12.99%298.74M |
Cost of revenue | -0.09%614.46M | -1.25%154.2M | -2.13%149.49M | 1.16%152.89M | 1.85%157.89M | 8.82%615.04M | 3.99%156.15M | 10.31%152.73M | 9.42%151.14M | 11.99%155.02M |
Gross profit | 5.15%582.79M | 15.07%162.46M | 8.59%145.66M | 1.66%137.43M | -4.50%137.25M | 5.65%554.22M | 1.04%141.18M | -0.53%134.13M | 8.99%135.19M | 14.08%143.72M |
Operating expense | 5.83%438.13M | 9.55%118.88M | 10.61%110.89M | 0.00%104.91M | 3.11%103.45M | 3.62%414M | 3.70%108.52M | -0.42%100.25M | 7.32%104.9M | 4.01%100.33M |
Selling and administrative expenses | 4.32%258.31M | 7.25%71.52M | 8.15%63.91M | -2.44%61.16M | 4.35%61.72M | 4.03%247.61M | 3.89%66.68M | 0.12%59.1M | 9.09%62.69M | 3.15%59.15M |
Research and development costs | 10.47%158.19M | 17.38%42.02M | 18.06%41.67M | 4.82%38.41M | 1.78%36.1M | 3.83%143.2M | 3.62%35.8M | -1.29%35.29M | 5.82%36.65M | 7.53%35.46M |
Depreciation amortization depletion | -6.76%21.62M | -11.57%5.34M | -9.37%5.31M | -4.23%5.34M | -1.47%5.64M | -1.73%23.19M | 2.05%6.03M | -0.58%5.86M | -1.38%5.57M | -6.81%5.72M |
-Depreciation and amortization | -6.76%21.62M | -11.57%5.34M | -9.37%5.31M | -4.23%5.34M | -1.47%5.64M | -1.73%23.19M | 2.05%6.03M | -0.58%5.86M | -1.38%5.57M | -6.81%5.72M |
Operating profit | 3.17%144.66M | 33.42%43.58M | 2.60%34.77M | 7.39%32.52M | -22.11%33.8M | 12.12%140.21M | -6.88%32.66M | -0.84%33.88M | 15.19%30.28M | 46.97%43.39M |
Net non-operating interest income expense | 18.84%-21.78M | 13.11%-5.44M | 14.65%-5.86M | 20.81%-5.6M | 26.47%-4.89M | -72.55%-26.84M | -7.89%-6.26M | -69.53%-6.86M | -175.98%-7.07M | -111.65%-6.65M |
Non-operating interest income | 100.30%8.69M | 12.31%2.04M | 63.57%1.92M | 172.41%2.1M | 359.75%2.62M | 394.41%4.34M | 435.29%1.82M | 318.15%1.18M | 512.70%772K | 337.69%569K |
Non-operating interest expense | -2.27%30.47M | -7.38%7.49M | -3.21%7.78M | -1.77%7.7M | 3.98%7.51M | 89.73%31.18M | 31.53%8.08M | 85.67%8.04M | 191.77%7.84M | 120.63%7.22M |
Other net income (expense) | 49.58%-10.6M | 130.30%2.9M | -1,413.27%-5.13M | -97.69%-6.93M | 81.12%-1.44M | 56.85%-21.02M | -852.54%-9.55M | 97.03%-339K | 78.85%-3.5M | 61.39%-7.63M |
Special income (charges) | 18.44%-13.32M | 83.79%-1.28M | -155.47%-2.94M | -242.12%-7.1M | 61.53%-2M | 64.72%-16.34M | -197,775.00%-7.92M | 91.88%-1.15M | 89.08%-2.08M | 60.37%-5.19M |
-Less:Restructuring and merger&acquisition | -18.44%13.32M | -83.79%1.28M | 155.47%2.94M | 242.12%7.1M | -61.53%2M | -64.72%16.34M | 197,775.00%7.92M | -91.88%1.15M | -89.08%2.08M | -60.37%5.19M |
Other non- operating income (expenses) | 158.11%2.72M | 354.91%4.18M | -369.00%-2.19M | 112.18%174K | 122.94%558K | -192.88%-4.69M | -64.06%-1.64M | -70.86%813K | -158.48%-1.43M | -399.51%-2.43M |
Income before tax | 21.57%112.27M | 143.58%41.03M | -10.88%23.78M | 1.45%20M | -5.65%27.47M | 51.94%92.35M | -40.41%16.84M | 42.54%26.68M | 175.13%19.71M | 339.15%29.11M |
Income tax | -2.62%25.42M | 57.19%6.56M | -41.28%4.69M | 7.14%6.17M | -2.26%8M | 56.12%26.11M | -48.58%4.17M | 28.05%7.99M | 211.63%5.76M | 1,485.85%8.18M |
Net income | 31.11%86.85M | 172.04%34.47M | 2.11%19.09M | -0.90%13.83M | -6.98%19.47M | 50.35%66.25M | -37.12%12.67M | 49.78%18.69M | 162.44%13.95M | 242.35%20.93M |
Net income continuous Operations | 31.11%86.85M | 172.04%34.47M | 2.11%19.09M | -0.90%13.83M | -6.98%19.47M | 50.35%66.25M | -37.12%12.67M | 49.78%18.69M | 162.44%13.95M | 242.35%20.93M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 31.11%86.85M | 172.04%34.47M | 2.11%19.09M | -0.90%13.83M | -6.98%19.47M | 50.35%66.25M | -37.12%12.67M | 49.78%18.69M | 162.44%13.95M | 242.35%20.93M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 31.11%86.85M | 172.04%34.47M | 2.11%19.09M | -0.90%13.83M | -6.98%19.47M | 50.35%66.25M | -37.12%12.67M | 49.78%18.69M | 162.44%13.95M | 242.35%20.93M |
Basic earnings per share | 38.46%3.06 | 179.55%1.23 | 8.06%0.67 | 4.35%0.48 | -1.45%0.68 | 55.63%2.21 | -33.33%0.44 | 55.00%0.62 | 170.59%0.46 | 263.16%0.69 |
Diluted earnings per share | 37.73%3.03 | 175.00%1.21 | 8.06%0.67 | 6.67%0.48 | 0.00%0.68 | 56.03%2.2 | -33.33%0.44 | 55.00%0.62 | 164.71%0.45 | 257.89%0.68 |
Dividend per share | 7.14%1.2 | 7.14%0.3 | 7.14%0.3 | 7.14%0.3 | 7.14%0.3 | 5.66%1.12 | 5.66%0.28 | 5.66%0.28 | 5.66%0.28 | 5.66%0.28 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |